The largest database of trusted experimental protocols

5 protocols using lenticrisprv2 blast plasmid

1

CRISPR-Mediated TRIT1 Knockout Generation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human TRIT1 mutant cells and control cells were generated using the CRISPR/Cas9 system essentially as described previously (Shalem et al. 2014 (link)). Briefly, sense and antisense oligonucleotides encoding a single guide RNA (sgRNA) against TRIT1 gene or a control sgRNA (not targeting human genome) (Supplemental Table 1; Shalem et al. 2014 (link)) were cloned into the BsmBI sites of lentiCRISPR v2 Blast plasmid (Addgene #83480). Lentiviruses were generated in HEK293FT cells by transfecting the sgRNA sequence-containing lentiCRISPR v2 Blast plasmid, psPAX2 plasmid (Addgene #12260) and pMD2.G plasmid (Addgene #12259) with Lipofectamine 3000 (Invitrogen). Fresh HEK293FT cells were transduced with the generated viruses, followed by blasticidin selection of the transduced cells. Subsequently, single clones were acquired by diluting the cells in 96-well plates followed by expansion of the clones. The target region of the genome in each clone was PCR-amplified and sequenced with conventional Sanger sequencing, using the primers listed in Supplemental Table 1.
+ Open protocol
+ Expand
2

CRISPR-Cas9 Mediated ADAR1 Knockout in iSLK.219 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
ADAR1 KO and ADAR1p150 KO iSLK.219 cell lines were generated via CRISPR-Cas9 genome editing. All gRNA sequences are the same as those used in a previous study (Chung et al., 2018 (link)) and are listed in Table S3. Briefly, gRNAs were cloned into LentiCRISPRv2 blast plasmid (Addgene) and transfected into 293FT cells along with ViraPower Lentiviral Packaging Mix (Invitrogen) using Lipofectamine 2000 (Invitrogen). Two days post transfection, the supernatant was collected, centrifuged and then transferred to iSLK.219 cells. Two days after infection, the iSLK.219 cells were selected with 10 μg/ml blasticidin (Invivogen) for 5 days and single cell colonies were isolated in 96-well plates and validated by immunoblotting using ADAR1 antibody.
+ Open protocol
+ Expand
3

Lentiviral CD1d1 and IFI204 constructs

Check if the same lab product or an alternative is used in the 5 most similar protocols
A lentiviral murine Cd1d1 expression construct (pLenti-Cd1d1-mGFP, Cat#MR226027L4) and its matched control construct (pLenti-C-mGFP, Cat#PS100093) were obtained from Origene. Murine Ifi204 expression vector (pLenti-Ifi204-Myc-DDK-Puro, Cat#MR222527L3), together with its control vector (pLenti-C-Myc-DDK-Puro, Cat#PS100092) were also purchased from Origene, and the puromycin selection cassette of these two Origene plasmids were replaced by blasticidin from lentiCRISPRv2-blast plasmid (Addgene#98293) using NEBuilder HiFi DNA Assembly Cloning kit (NEB, Cat#E5520S). For the LLC-1 experiment, the murine Cd1d1 was cloned into the receiving vector N174-MCS (Addgene#81061) with the restriction enzymes EcoR1 and Mlu1, using the FastDigest protocol of Thermo Scientific. All final construct sequences were confirmed by Sanger sequencing. Plasmids generated in this study are available upon written request.
+ Open protocol
+ Expand
4

Lentiviral CD1d1 and IFI204 constructs

Check if the same lab product or an alternative is used in the 5 most similar protocols
A lentiviral murine Cd1d1 expression construct (pLenti-Cd1d1-mGFP, Cat#MR226027L4) and its matched control construct (pLenti-C-mGFP, Cat#PS100093) were obtained from Origene. Murine Ifi204 expression vector (pLenti-Ifi204-Myc-DDK-Puro, Cat#MR222527L3), together with its control vector (pLenti-C-Myc-DDK-Puro, Cat#PS100092) were also purchased from Origene, and the puromycin selection cassette of these two Origene plasmids were replaced by blasticidin from lentiCRISPRv2-blast plasmid (Addgene#98293) using NEBuilder HiFi DNA Assembly Cloning kit (NEB, Cat#E5520S). For the LLC-1 experiment, the murine Cd1d1 was cloned into the receiving vector N174-MCS (Addgene#81061) with the restriction enzymes EcoR1 and Mlu1, using the FastDigest protocol of Thermo Scientific. All final construct sequences were confirmed by Sanger sequencing. Plasmids generated in this study are available upon written request.
+ Open protocol
+ Expand
5

CRISPR-Cas9 Mediated ADAR1 Knockout in iSLK.219 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
ADAR1 KO and ADAR1p150 KO iSLK.219 cell lines were generated via CRISPR-Cas9 genome editing. All gRNA sequences are the same as those used in a previous study (Chung et al., 2018 (link)) and are listed in Table S3. Briefly, gRNAs were cloned into LentiCRISPRv2 blast plasmid (Addgene) and transfected into 293FT cells along with ViraPower Lentiviral Packaging Mix (Invitrogen) using Lipofectamine 2000 (Invitrogen). Two days post transfection, the supernatant was collected, centrifuged and then transferred to iSLK.219 cells. Two days after infection, the iSLK.219 cells were selected with 10 μg/ml blasticidin (Invivogen) for 5 days and single cell colonies were isolated in 96-well plates and validated by immunoblotting using ADAR1 antibody.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!